You are here

  • Home
  • Archive
  • Volume 68, Issue 5
  • Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study

Citation Tools

Article menu

Download PDFPDF

Clinical and epidemiological research
Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Rudwaleit M, Rødevand E, Holck P, et al
Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study
Annals of the Rheumatic Diseases 2009;68:696-701.